Nanopore Diagnostics is developing a rapid and portable bacterial diagnostic assay.
Our test will allow a physician to make an informed antibiotic decision during their initial examination of a patient, ensuring antibiotics are only administered when truly needed. Our core technology for counting specific nucleic acid biomarkers is quicker, simpler, and more accurate than current methods.
Cohorts
Industries
Financials
- $600k